作者: Anna Karawajczyk , Fabrizio Giordanetto , Jorg Benningshof , Daniel Hamza , Tuomo Kalliokoski
DOI: 10.1016/J.DRUDIS.2015.09.009
关键词:
摘要: High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability an innovative, relevant and high-quality compound collection to be screened often dictates the final fate discovery campaign. Given that chemical space sampled in research programs is practically infinite sparsely populated, significant efforts resources need invested generation maintenance competitive collection. European Lead Factory (ELF) project addressing this challenge by leveraging diverse experience know-how academic groups small medium enterprises (SMEs) engaged synthetic and/or medicinal chemistry. Here, we describe novelty, diversity, structural complexity, physicochemical characteristics overall attractiveness first batch ELF compounds for HTS purposes.